| scholarly article | Q13442814 |
| P2093 | author name string | Kohichiro Iwasaki | |
| P2860 | cites work | Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation | Q84480239 |
| Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction | Q84567934 | ||
| Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention | Q22241918 | ||
| Paradigm shift to functional angioplasty: new insights for fractional flow reserve- and intravascular ultrasound-guided percutaneous coronary intervention | Q26863709 | ||
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
| Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials | Q28202129 | ||
| Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses | Q28279558 | ||
| Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II | Q28296568 | ||
| Fractional flow reserve versus angiography for guiding percutaneous coronary intervention | Q28306779 | ||
| Frequency and prognostic value of cardiac troponin I elevation after coronary stenting | Q78245234 | ||
| Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy | Q80681924 | ||
| Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) stud | Q84383774 | ||
| Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease | Q30311022 | ||
| Fractional flow reserve: critical review of an important physiologic adjunct to angiography | Q30433498 | ||
| Comparison between angiography and fractional flow reserve versus single-photon emission computed tomographic myocardial perfusion imaging for determining lesion significance in patients with multivessel coronary disease | Q30443315 | ||
| Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infa | Q30654016 | ||
| Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis | Q30809829 | ||
| Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. | Q33872047 | ||
| Evaluation of the culprit plaque and the physiological significance of coronary atherosclerotic narrowings | Q34293140 | ||
| Third universal definition of myocardial infarction | Q34295914 | ||
| A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents | Q34374902 | ||
| Optimal medical therapy with or without PCI for stable coronary disease | Q34612445 | ||
| Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition | Q34962673 | ||
| Appropriateness of percutaneous coronary intervention | Q35800916 | ||
| Optimum guidance of complex PCI by coronary pressure measurement | Q35862860 | ||
| Physiological basis of clinically used coronary hemodynamic indices | Q36375835 | ||
| Assessment of intermediate severity coronary lesions in the catheterization laboratory | Q36744583 | ||
| Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis | Q37089842 | ||
| Fractional flow reserve: a review: invasive imaging | Q37190749 | ||
| Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention | Q37229110 | ||
| Angioplasty strategies in ST-segment-elevation myocardial infarction: part II: intervention after fibrinolytic therapy, integrated treatment recommendations, and future directions | Q37229114 | ||
| The American Heart Association's 2008 Statement of Principles for Healthcare Reform | Q37280347 | ||
| ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Societ | Q37365044 | ||
| Current concepts of integrated coronary physiology in the catheterization laboratory | Q37684401 | ||
| 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q37953802 | ||
| Functional measurement of coronary stenosis | Q37993997 | ||
| Cardiovascular disease epidemiology in Asia: an overview. | Q38117214 | ||
| Epidemiology of stroke and coronary artery disease in Asia | Q38120611 | ||
| Impact of ischemia-guided revascularization with myocardial perfusion imaging for patients with multivessel coronary disease | Q38460721 | ||
| Quantitative evaluation of exercise Tl-201 myocardial scintigraphy before and after transluminal coronary angioplasty A preliminary report | Q38480279 | ||
| Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial | Q39414080 | ||
| Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affa | Q39455534 | ||
| The Medicine, Angioplasty or Surgery Study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses | Q39470269 | ||
| A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators | Q39504139 | ||
| Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography | Q40585925 | ||
| Troponin I elevation and cardiac events after percutaneous coronary intervention | Q40597913 | ||
| Current status of myocardial perfusion imaging after percutaneous transluminal coronary angioplasty | Q40658331 | ||
| Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging | Q40850909 | ||
| Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months | Q41037397 | ||
| ??? | Q28252529 | ||
| Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain | Q41446749 | ||
| Incomplete redistribution in delayed thallium-201 single photon emission computed tomographic (SPECT) images: an overestimation of myocardial scarring | Q41866495 | ||
| Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease | Q43124900 | ||
| Effectiveness of myocardial perfusion scintigraphy to predict coronary anatomy in patients with non-ST elevation acute coronary syndrome. | Q43287859 | ||
| Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention | Q43664964 | ||
| Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients | Q43698882 | ||
| Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease | Q43926636 | ||
| Frequency and long-term impact of myonecrosis after coronary stenting | Q44012971 | ||
| Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy | Q44123750 | ||
| Prognostic implication of troponin I elevation after percutaneous coronary intervention | Q44439762 | ||
| Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era. | Q44471766 | ||
| Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention | Q44620714 | ||
| Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. | Q44707476 | ||
| Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions | Q44799240 | ||
| Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures | Q45056643 | ||
| Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia | Q45253615 | ||
| Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study | Q45291455 | ||
| Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiol | Q46215425 | ||
| Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? | Q46263015 | ||
| Appropriateness of coronary revascularization for patients without acute coronary syndromes | Q47749030 | ||
| Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. | Q51017150 | ||
| Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. | Q51037352 | ||
| Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization. | Q51824558 | ||
| Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. | Q53237676 | ||
| Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. | Q53248514 | ||
| Important parameters in the detection of left main trunk disease using stress myocardial perfusion imaging. | Q53372351 | ||
| Underestimation of coronary artery disease with SPECT perfusion imaging. | Q53426624 | ||
| Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. | Q53469915 | ||
| Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. | Q53546899 | ||
| Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status. | Q54545958 | ||
| Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial | Q60607069 | ||
| Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease | Q61651378 | ||
| Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease | Q70018282 | ||
| Prognostic value of computer-quantitated exercise thallium imaging early after percutaneous transluminal coronary angioplasty | Q70032465 | ||
| Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities | Q70042527 | ||
| Thallium-201 myocardial perfusion imaging in patients before and after successful percutaneous transluminal coronary angioplasty | Q71503543 | ||
| Short- and long-term changes in myocardial perfusion after percutaneous transluminal coronary angioplasty assessed by thallium-201 exercise scintigraphy | Q71537512 | ||
| Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography | Q71977968 | ||
| Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo | Q72665772 | ||
| A new approach to quantitation of exercise thallium-201 scintigraphy before and after an intervention: Application to define the impact of coronary angioplasty on regional myocardial perfusion | Q72826716 | ||
| Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants | Q73634345 | ||
| Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions | Q73713092 | ||
| Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction | Q74288420 | ||
| Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease | Q74319206 | ||
| Prognostic value of myocardial perfusion imaging in patients with high exercise tolerance | Q74459703 | ||
| The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group | Q77407529 | ||
| How well does radionuclide dipyridamole stress testing detect three-vessel coronary artery disease and ischemia in the region supplied by the most stenotic vessel? | Q77799557 | ||
| Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris | Q77997673 | ||
| P433 | issue | 4 | |
| P921 | main subject | coronary artery disease | Q844935 |
| myocardial ischemia | Q6947906 | ||
| P304 | page(s) | 130-139 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | World journal of cardiology | Q27723312 |
| P1476 | title | Myocardial ischemia is a key factor in the management of stable coronary artery disease | |
| P478 | volume | 6 |
| Q89977256 | An Upfront Two-Stent Strategy for True Coronary Bifurcation Lesions with A Large Side Branch in Acute Coronary Syndrome: A Two-Year Follow-Up Study |
| Q89099762 | Apigenin suppresses the apoptosis of H9C2 rat cardiomyocytes subjected to myocardial ischemia‑reperfusion injury via upregulation of the PI3K/Akt pathway |
| Q57725615 | CT Myocardial Perfusion Imaging: A New Frontier in Cardiac Imaging |
| Q90116152 | Cardiovascular magnetic resonance: Stressing the future |
| Q92108235 | Clinical Applications of Wide-Detector CT Scanners for Cardiothoracic Imaging: An Update |
| Q90654642 | Comparison between minimum lumen cross-sectional area and intraluminal ultrasonic intensity analysis using integrated backscatter intravascular ultrasound for prediction of functionally significant coronary artery stenosis |
| Q38843460 | FFR and iFR guided percutaneous coronary intervention |
| Q40085577 | Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study. |
| Q42339377 | The Impact of Fractional Flow Reserve-Guided Coronary Revascularization in Patients with Coronary Stenoses of Intermediate Severity |
Search more.